
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK–driven lymphomagenesis
Elisa Redl, Raheleh Sheibani‐Tezerji, Crhistian de Jesus Cardona, et al.
Life Science Alliance (2020) Vol. 4, Iss. 2, pp. e202000794-e202000794
Open Access | Times Cited: 8
Elisa Redl, Raheleh Sheibani‐Tezerji, Crhistian de Jesus Cardona, et al.
Life Science Alliance (2020) Vol. 4, Iss. 2, pp. e202000794-e202000794
Open Access | Times Cited: 8
Showing 8 citing articles:
Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis
Jangho Lee, Ji‐Hye Song, Jae‐Ho Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 143-157
Open Access | Times Cited: 13
Jangho Lee, Ji‐Hye Song, Jae‐Ho Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 1, pp. 143-157
Open Access | Times Cited: 13
PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
Ines Garces de los Fayos Alonso, L. Zujo, I. Wiest, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Ines Garces de los Fayos Alonso, L. Zujo, I. Wiest, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 19
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
Leukemia (2025)
Open Access
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
Leukemia (2025)
Open Access
Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells
Yutao Li, Amit Sharma, Michèle J. Hoffmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Yutao Li, Amit Sharma, Michèle J. Hoffmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Updates in pathobiological aspects of anaplastic large cell lymphoma
Rui Wu, Megan S. Lim
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Rui Wu, Megan S. Lim
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
HDAC1 acts as tumor suppressor in ALK-positive anaplastic large-cell lymphoma: Implications for HDAC inhibitor therapy
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Maša Zrimšek, Kristina Draganić, Anna Malzer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida‐Sakai, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5089-5089
Open Access | Times Cited: 1
Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida‐Sakai, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5089-5089
Open Access | Times Cited: 1
Synergistic effects of cannabidiol and cytokine-induced killer cells via the modulation of TRPV2 channel and intracellular p-ERK 1/2 expression on non-small cell lung cancer cells
Yutao Li, Amit Sharma, Michèle J. Hoffmann, et al.
Research Square (Research Square) (2023)
Open Access
Yutao Li, Amit Sharma, Michèle J. Hoffmann, et al.
Research Square (Research Square) (2023)
Open Access